Sponsor

Solvay Pharmaceuticals

Clinical research sponsor

Published trials62

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male VolunteersNCT01088594 · lead sponsor · 2010-02-01

COMPLETED

Interaction Study SLV337/SimvastatinNCT00924430 · lead sponsor · 2009-06-01

COMPLETED

Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart FailureNCT00744341 · lead sponsor · 2009-02-01

TERMINATED

First in Man Study With SLV341NCT00887445 · lead sponsor · 2008-07-01

TERMINATED

BMS-646256 in Obese and Overweight Type 2 DiabeticsNCT00541567 · lead sponsor · 2008-03-01

WITHDRAWN

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal FunctionNCT00568009 · lead sponsor · 2007-10-01

TERMINATED

Effect of Omacor on Triglycerides in HIV Infected SubjectsNCT00598910 · lead sponsor · 2007-08-01

TERMINATED

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.NCT00407095 · lead sponsor · 2007-08-01

COMPLETED

An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsNCT00335374 · lead sponsor · 2007-08-01

COMPLETED

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsNCT00396214 · lead sponsor · 2007-04-01

TERMINATED

SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsNCT00406588 · lead sponsor · 2007-03-01

COMPLETED

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaNCT00490178 · lead sponsor · 2007-03-01

COMPLETED

An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD PatientsNCT00332917 · lead sponsor · 2007-02-01

COMPLETED

Switch Study of Existing Atypical Antipsychotics to BifeprunoxNCT00347425 · lead sponsor · 2006-12-01

COMPLETED

SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson DiseaseNCT00335166 · lead sponsor · 2006-11-01

COMPLETED

Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudyNCT00362765 · lead sponsor · 2006-10-01

TERMINATED

Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFONCT00362323 · lead sponsor · 2006-10-01

COMPLETED

Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and AdolescentsNCT00353028 · lead sponsor · 2006-10-01

COMPLETED

Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSINCT00361868 · lead sponsor · 2006-06-01

TERMINATED

SLV308 for Treatment of Patients With Early Parkinson's DiseaseNCT00269516 · lead sponsor · 2006-06-01

COMPLETED

Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderNCT00139919 · lead sponsor · 2006-01-01

COMPLETED

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeNCT00160147 · lead sponsor · 2005-12-01

TERMINATED

Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's DiseaseNCT00134251 · lead sponsor · 2005-10-01

COMPLETED

Effect of Fenofibrate on Sleep Apnea SyndromeNCT00816829 · lead sponsor · 2005-09-01

TERMINATED

Bifeprunox in the Treatment of SchizophreniaNCT00193687 · lead sponsor · 2005-09-01

COMPLETED

Twice Daily Titration Study of Bifeprunox in Subjects With SchizophreniaNCT00139906 · lead sponsor · 2005-08-01

COMPLETED

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled HypertensionNCT00160225 · lead sponsor · 2005-07-01

COMPLETED

Efficacy and Safety of Moxonidine in Indian PatientsNCT00160277 · lead sponsor · 2005-07-01

COMPLETED

Patient-reported Outcomes in the Treatment of SchizophreniaNCT00230828 · lead sponsor · 2005-05-01

COMPLETED

Bifeprunox in the Treatment of SchizophreniaNCT00193713 · lead sponsor · 2005-05-01

COMPLETED

To Evaluate the Impact of Treatment Interruption on Re-initiation of BifeprunoxNCT00141479 · lead sponsor · 2005-05-01

COMPLETED

Acceptability of a Fixed Combination of Fenofibrate and MetforminNCT00348725 · lead sponsor · 2005-04-01

COMPLETED

Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart FailureNCT00160134 · lead sponsor · 2005-01-01

COMPLETED

Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionNCT00160212 · lead sponsor · 2004-12-01

COMPLETED

Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesNCT00160160 · lead sponsor · 2004-10-01

COMPLETED

Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesNCT00141492 · lead sponsor · 2004-10-01

COMPLETED

A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.NCT00349635 · lead sponsor · 2004-10-01

COMPLETED

Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesNCT00349128 · lead sponsor · 2004-01-01

COMPLETED

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingNCT00642499 · lead sponsor · 2003-08-01

COMPLETED

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesNCT00703482 · lead sponsor · 2003-05-01

COMPLETED

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.NCT00703755 · lead sponsor · 2003-03-01

COMPLETED

Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and DiabetesNCT00440440 · collaborator · 2009-08-01

WITHDRAWN

Hormone and Information Processing StudyNCT00539305 · collaborator · 2009-07-01

COMPLETED

Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's DiseaseNCT00914134 · collaborator · 2009-04-01

COMPLETED

Study Evaluating Multiple Ascending Dose in Schizophrenia PatientsNCT00620568 · collaborator · 2008-02-01

TERMINATED

Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia PatientsNCT00581243 · collaborator · 2008-01-01

TERMINATED

Effect of Testosterone Replacement on Insulin ResistanceNCT00487734 · collaborator · 2007-08-01

COMPLETED

Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass PatientsNCT00510744 · collaborator · 2007-08-01

COMPLETED

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate CancerNCT00515112 · collaborator · 2007-07-01

TERMINATED

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic HypogonadismNCT00467987 · collaborator · 2007-06-01

TERMINATED

Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low TestosteroneNCT00392912 · collaborator · 2007-04-01

COMPLETED

Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes MellitusNCT00328536 · collaborator · 2007-04-01

COMPLETED

Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary EndpointNCT00366704 · collaborator · 2006-11-01

TERMINATED

Multiple-dose Study to Evaluate the Efficacy, Safety and Pharmacokinetics of BMS-646256 in Obese SubjectsNCT00388609 · collaborator · 2006-11-01

TERMINATED

Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese MenNCT00365794 · collaborator · 2006-08-01

COMPLETED

Effect of Androgel on Type 2 Diabetic Males With HypogonadismNCT00350701 · collaborator · 2006-07-01

COMPLETED

AndroGel in Men With Major Depression and Incomplete Response to Antidepressant TreatmentNCT00304746 · collaborator · 2006-04-01

COMPLETED

Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefitNCT00272688 · collaborator · 2006-01-01

COMPLETED

Bifeprunox Extension to Extension Study in Patients With SchizophreniaNCT00861497 · collaborator · 2006-01-01

TERMINATED

Influenza Vaccination in Immunocompromized PatientsNCT00783380 · collaborator · 2005-10-01

COMPLETED

Sponsor roles

lead sponsor41

collaborator21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.